Literature DB >> 26999952

Prevalence of Polyoma BK Virus (BKPyV), Epstein-Barr Virus (EBV) and Human Papilloma Virus (HPV) in Oropharyngeal Cancer.

Dorota Polz-Gruszka, Kamal Morshed, Adrian Jarzyński, Małgorzata Polz-Dacewicz.   

Abstract

The aim of this study was to analyze the prevalence of BK virus, Human Papillomavirus and Epstein-Barr virus in oropharyngeal cancer, and to test our hypothesis that BKV/HPV/EBV co-infection plays a role in oropharyngeal squamous cell carcinoma. The correlation between viral infection, OSCC, anatomic location, pre-treatment staging, evidence of metastases to lymph nodes, and grading was also investigated. The examination samples were collected from 62 patients from paraffin tissue blocks. Males (90.3%) with, smoking (83.9%) and alcohol abuse (67.7%) problems prevailed in the studied group. G2 histological type was recognized in 80.6% cases. T4 (77.4%) and N2 (56.5%) traits occurred in the majority of patients. No cases of metastasis were observed (M0 100%). HPV - 24.2%, EBV - 27.4% and BKV 17.7% were detected in the studied samples. We observed co-infection EBV/BKV in 8% of cases, HPV/BKV in 4.8%, and HPV/EBV in 9% cases. Only in two cases co-infection of all three viruses was found.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26999952     DOI: 10.5604/17331331.1185229

Source DB:  PubMed          Journal:  Pol J Microbiol        ISSN: 1733-1331


  11 in total

Review 1.  Epstein-Barr virus in the pathogenesis of oral cancers.

Authors:  J T Guidry; C E Birdwell; R S Scott
Journal:  Oral Dis       Date:  2017-04-18       Impact factor: 3.511

Review 2.  The interaction between human papillomavirus and other viruses.

Authors:  J T Guidry; R S Scott
Journal:  Virus Res       Date:  2016-11-05       Impact factor: 3.303

3.  Prevalence of Human Papillomavirus (HPV) in the Oral Cavity of a Healthy Population in South-Eastern Poland.

Authors:  Marcin Koleśnik; Ewa Stępień; Małgorzata Polz-Dacewicz
Journal:  Int J Environ Res Public Health       Date:  2022-06-12       Impact factor: 4.614

4.  Coinfection with Epstein-Barr Virus (EBV), Human Papilloma Virus (HPV) and Polyoma BK Virus (BKPyV) in Laryngeal, Oropharyngeal and Oral Cavity Cancer.

Authors:  Bartłomiej Drop; Małgorzata Strycharz-Dudziak; Ewa Kliszczewska; Małgorzata Polz-Dacewicz
Journal:  Int J Mol Sci       Date:  2017-12-19       Impact factor: 5.923

5.  Polyomaviruses detectable in head and neck carcinomas.

Authors:  Leonard Poluschkin; Jaana Rautava; Aaro Turunen; Yilin Wang; Klaus Hedman; Kari Syrjänen; Reidar Grenman; Stina Syrjänen
Journal:  Oncotarget       Date:  2018-04-27

6.  Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact.

Authors:  Timo Carpén; Stina Syrjänen; Lauri Jouhi; Reija Randen-Brady; Caj Haglund; Antti Mäkitie; Petri S Mattila; Jaana Hagström
Journal:  Cancer Immunol Immunother       Date:  2020-04-20       Impact factor: 6.968

7.  Merkel cell polyomavirus detected in head and neck carcinomas from Chile.

Authors:  Juan P Muñoz; Rancés Blanco; Julio C Osorio; Carolina Oliva; María José Diaz; Diego Carrillo-Beltrán; Rebeca Aguayo; Andrés Castillo; Julio C Tapia; Gloria M Calaf; Aldo Gaggero; Francisco Aguayo
Journal:  Infect Agent Cancer       Date:  2020-01-28       Impact factor: 2.965

8.  Polyomavirus JCPyV infrequently detectable in adenoid cystic carcinoma of the oral cavity and the airways.

Authors:  Hanna Hämetoja; Jaana Hagström; Caj Haglund; Leif Bäck; Antti Mäkitie; Stina Syrjänen
Journal:  Virchows Arch       Date:  2019-07-01       Impact factor: 4.064

Review 9.  High-Risk Human Papillomavirus and Epstein-Barr Virus Coinfection: A Potential Role in Head and Neck Carcinogenesis.

Authors:  Rancés Blanco; Diego Carrillo-Beltrán; Alejandro H Corvalán; Francisco Aguayo
Journal:  Biology (Basel)       Date:  2021-11-26

10.  Reciprocal transactivation of Merkel cell polyomavirus and high-risk human papillomavirus promoter activities and increased expression of their oncoproteins.

Authors:  Kashif Rasheed; Baldur Sveinbjørnsson; Ugo Moens
Journal:  Virol J       Date:  2021-07-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.